AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
CONCURRENT DISRUPTION OF CELL-CYCLE ASSOCIATED GENES IN MANTLE CELL LYMPHOMA - A GENOTYPIC AND PHENOTYPIC STUDY OF CYCLIN D1, P16, P15, P53AND PRB
Authors: GRONBAEK K NEDERGAARD T ANDERSEN MK STRATEN PT GULDBERG P MOLLER P ZEUTHEN J HANSEN NE HOUJENSEN K RALFKIAER E
Citation: K. Gronbaek et al., CONCURRENT DISRUPTION OF CELL-CYCLE ASSOCIATED GENES IN MANTLE CELL LYMPHOMA - A GENOTYPIC AND PHENOTYPIC STUDY OF CYCLIN D1, P16, P15, P53AND PRB, Leukemia, 12(8), 1998, pp. 1266-1271
SOMATIC FAS MUTATIONS IN NON-HODGKINS-LYMPHOMA - ASSOCIATION WITH EXTRANODAL DISEASE AND AUTOIMMUNITY
Authors: GRONBAEK K STRATEN PT RALFKIAER E AHRENKIEL V ANDERSEN MK HANSEN NE ZEUTHEN J HOUJENSEN K GULDBERG P
Citation: K. Gronbaek et al., SOMATIC FAS MUTATIONS IN NON-HODGKINS-LYMPHOMA - ASSOCIATION WITH EXTRANODAL DISEASE AND AUTOIMMUNITY, Blood, 92(9), 1998, pp. 3018-3024
PIECING THE PUZZLE TOGETHER - A MODEL FOR UNDERSTANDING THE THEORY-PRACTICE RELATIONSHIP
Authors: HANSEN NE FREIMUTH M
Citation: Ne. Hansen et M. Freimuth, PIECING THE PUZZLE TOGETHER - A MODEL FOR UNDERSTANDING THE THEORY-PRACTICE RELATIONSHIP, The Counseling psychologist, 25(4), 1997, pp. 654-673
CONCURRENT DISRUPTION OF CELL-CYCLE ASSOCIATED GENES IN AGGRESSIVE VARIANTS OF MANTLE CELL LYMPHOMAS (MCL)
Authors: GRONBAEK K GULDBERG P NEDERGAARD T ANDERSEN MK MOLLER P HANSEN NE HOUJENSEN K ZEUTHEN J RALFKIAER E
Citation: K. Gronbaek et al., CONCURRENT DISRUPTION OF CELL-CYCLE ASSOCIATED GENES IN AGGRESSIVE VARIANTS OF MANTLE CELL LYMPHOMAS (MCL), Blood, 90(10), 1997, pp. 3897-3897
IN B-CLL, CHLORAMBUCIL AND CHOP GIVE EQUAL SURVIVAL AND CHROMOSOME-17ABNORMALITIES IS THE SINGLE MOST IMPORTANT FACTOR FOR THE OUTCOME OF TREATMENT - A CYTOGENETIC, IMMUNOPHENOTYPIC AND BONE-MARROW HISTOLOGICAL STUDY OF 175 CONSECUTIVE NEWLY-DIAGNOSED PATIENTS RANDOMIZED TO EITHER CHOP OR CHLORAMBUCIL PLUS PREDNISOLONE
Authors: GEISLER CH HANSEN MM PHILIP P CHRISTENSEN BE HOUJENSEN K TINGGAARDPEDERSEN N JENSEN OM THORLING K ANDERSEN E HANSEN NE NIELSEN H NIELSEN JB ELLEGAARD J LARSEN JK BROWN P ANDERSEN PK
Citation: Ch. Geisler et al., IN B-CLL, CHLORAMBUCIL AND CHOP GIVE EQUAL SURVIVAL AND CHROMOSOME-17ABNORMALITIES IS THE SINGLE MOST IMPORTANT FACTOR FOR THE OUTCOME OF TREATMENT - A CYTOGENETIC, IMMUNOPHENOTYPIC AND BONE-MARROW HISTOLOGICAL STUDY OF 175 CONSECUTIVE NEWLY-DIAGNOSED PATIENTS RANDOMIZED TO EITHER CHOP OR CHLORAMBUCIL PLUS PREDNISOLONE, Blood, 90(10), 1997, pp. 2358-2358
THE BONE-MARROW INFILTRATION PATTERN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS NOT AN IMPORTANT PROGNOSTIC FACTOR
Authors: GEISLER CH HOUJENSEN K JENSEN OM TINGGARDPEDERSEN N HANSEN MM HANSEN NE HOLM M CHRISTENSEN BE DRIVSHOLM A NIELSEN JB THORLING K ANDERSEN E
Citation: Ch. Geisler et al., THE BONE-MARROW INFILTRATION PATTERN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS NOT AN IMPORTANT PROGNOSTIC FACTOR, European journal of haematology, 57(4), 1996, pp. 292-300
TEACHING GRADUATE PSYCHOLOGY SEMINARS USING ELECTRONIC MAIL - CREATIVE DISTANCE EDUCATION
Authors: HANSEN NE GLADFELTER J
Citation: Ne. Hansen et J. Gladfelter, TEACHING GRADUATE PSYCHOLOGY SEMINARS USING ELECTRONIC MAIL - CREATIVE DISTANCE EDUCATION, Teaching of psychology, 23(4), 1996, pp. 252-256
IMPAIRED MIGRATION IN-VITRO OF NEUTROPHILS FROM PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
Authors: PEDERSEN TL YONG K PEDERSEN JO HANSEN NE DANO K PLESNER T
Citation: Tl. Pedersen et al., IMPAIRED MIGRATION IN-VITRO OF NEUTROPHILS FROM PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, British Journal of Haematology, 95(1), 1996, pp. 45-51
TRISOMY-12 IS FOUND IN CLL WITH BOTH TYPICAL AND ATYPICAL IMMUNOPHENOTYPE AND HAS NO PROGNOSTIC-SIGNIFICANCE - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480 UNSELECTED NEWLY-DIAGNOSED PATIENTS
Authors: GEISLER CH PHILIP P CHRISTENSEN BE HOUJENSEN K PEDERSEN NT JENSEN OM THORLING K ANDERSEN E HANSEN NE NIELSEN H ELLEGAARD J LARSEN JK BROWN P ANDERSEN PK HANSEN MM
Citation: Ch. Geisler et al., TRISOMY-12 IS FOUND IN CLL WITH BOTH TYPICAL AND ATYPICAL IMMUNOPHENOTYPE AND HAS NO PROGNOSTIC-SIGNIFICANCE - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480 UNSELECTED NEWLY-DIAGNOSED PATIENTS, Blood, 88(10), 1996, pp. 937-937
SHORT-TERM RHG-CSF PRIMING BEFORE CHEMOTHERAPY DOES MOBILIZE BLOOD PROGENITORS BUT DOES NOT PREVENT CHEMOTHERAPY-INDUCED MYELOTOXICITY - A RANDOMIZED STUDY OF PATIENTS WITH NON-HODGKINS-LYMPHOMAS
Authors: HANSEN PB JOHNSEN HE RALFKIAER E JENSEN L GAARSDAL E HANSEN NE
Citation: Pb. Hansen et al., SHORT-TERM RHG-CSF PRIMING BEFORE CHEMOTHERAPY DOES MOBILIZE BLOOD PROGENITORS BUT DOES NOT PREVENT CHEMOTHERAPY-INDUCED MYELOTOXICITY - A RANDOMIZED STUDY OF PATIENTS WITH NON-HODGKINS-LYMPHOMAS, Leukemia & lymphoma, 19(5-6), 1995, pp. 453-460
STIMULATION TESTS FOR THE BONE-MARROW NEUTROPHIL POOL IN MALIGNANCIES
Authors: HANSEN PB KNUDSEN LM JOHNSEN HE HANSEN NE
Citation: Pb. Hansen et al., STIMULATION TESTS FOR THE BONE-MARROW NEUTROPHIL POOL IN MALIGNANCIES, Leukemia & lymphoma, 16(3-4), 1995, pp. 237-246
THE IN-VIVO ERYTHROPOIESIS OF PATIENTS WITH POLYCYTHEMIA-VERA IS INSENSITIVE TO STIMULATION WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
Authors: NIELSEN OJ HANSEN NE KARLE H THEILGAARD G SKOV PS
Citation: Oj. Nielsen et al., THE IN-VIVO ERYTHROPOIESIS OF PATIENTS WITH POLYCYTHEMIA-VERA IS INSENSITIVE TO STIMULATION WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, European journal of haematology, 54(3), 1995, pp. 195-196
UNEXPECTED HEPATOTOXICITY AFTER PRIMING AND TREATMENT WITH MOLGRAMOSTIM (RHGM-CSF) IN ACUTE MYELOID-LEUKEMIA DURING INDUCTION CHEMOTHERAPY
Authors: HANSEN PB JOHNSEN HE LUND JO HANSEN MS HANSEN NE
Citation: Pb. Hansen et al., UNEXPECTED HEPATOTOXICITY AFTER PRIMING AND TREATMENT WITH MOLGRAMOSTIM (RHGM-CSF) IN ACUTE MYELOID-LEUKEMIA DURING INDUCTION CHEMOTHERAPY, American journal of hematology, 48(1), 1995, pp. 48-51
THE RECEPTOR FOR UROKINASE PLASMINOGEN-ACTIVATOR IS PRESENT IN PLASMAFROM HEALTHY DONORS AND ELEVATED IN PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
Authors: RONNE E PAPPOT H GRONDAHLHANSEN J HOYERHANSEN G PLESNER T HANSEN NE DANO K
Citation: E. Ronne et al., THE RECEPTOR FOR UROKINASE PLASMINOGEN-ACTIVATOR IS PRESENT IN PLASMAFROM HEALTHY DONORS AND ELEVATED IN PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, British Journal of Haematology, 89(3), 1995, pp. 576-581
IMPAIRED MIGRATION IN-VITRO OF NEUTROPHILS FROM PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
Authors: PEDERSEN TL YONG K PEDERSEN JO HANSEN NE DANO K PLESNER T
Citation: Tl. Pedersen et al., IMPAIRED MIGRATION IN-VITRO OF NEUTROPHILS FROM PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, Blood, 86(10), 1995, pp. 2829-2829
PRIMING WITH RECOMBINANT HUMAN HEMATOPOIETIC CYTOKINES BEFORE BONE-MARROW HARVEST EXPANDS IN-VIVO AND ENHANCES EX-VIVO RECOVERY OF MYELOID PROGENITORS IN SHORT-TERM LIQUID CULTURES
Authors: JOHNSEN HE JENSEN L GAARSDAL E HANSEN PB ERSBOLL J HANSEN NE
Citation: He. Johnsen et al., PRIMING WITH RECOMBINANT HUMAN HEMATOPOIETIC CYTOKINES BEFORE BONE-MARROW HARVEST EXPANDS IN-VIVO AND ENHANCES EX-VIVO RECOVERY OF MYELOID PROGENITORS IN SHORT-TERM LIQUID CULTURES, Experimental hematology, 22(1), 1994, pp. 80-86
SERUM TRANSFERRIN RECEPTOR LEVELS IN ANEMIC PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: NIELSEN OJ ANDERSEN LS HANSEN NE HANSEN TM
Citation: Oj. Nielsen et al., SERUM TRANSFERRIN RECEPTOR LEVELS IN ANEMIC PATIENTS WITH RHEUMATOID-ARTHRITIS, Scandinavian journal of clinical & laboratory investigation, 54(1), 1994, pp. 75-82
A CRITIQUE OF CARDENS INTEGRATIVE MODEL FOR TREATMENT OF BATTERERS - ONE CLINICIAN PERSPECTIVE
Authors: HANSEN NE
Citation: Ne. Hansen, A CRITIQUE OF CARDENS INTEGRATIVE MODEL FOR TREATMENT OF BATTERERS - ONE CLINICIAN PERSPECTIVE, The Counseling psychologist, 22(4), 1994, pp. 583-586
NEUTROPHIL INCREMENT AFTER SINGLE INJECTION OF CSF
Authors: JOHNSEN HE HANSEN PB HANSEN NE RALFKIAER E
Citation: He. Johnsen et al., NEUTROPHIL INCREMENT AFTER SINGLE INJECTION OF CSF, British Journal of Haematology, 86(2), 1994, pp. 447-447
DIFFERENT MEMBRANE EXPRESSION OF CD11B AND CD14 ON BLOOD NEUTROPHILS FOLLOWING IN-VIVO ADMINISTRATION OF MYELOID GROWTH-FACTORS (VOL 85, PG50, 1993)
Authors: HANSEN PB KJAERSGAARD E JOHNSEN HE GRAM J PEDERSEN M NIKOLAJSEN K HANSEN NE
Citation: Pb. Hansen et al., DIFFERENT MEMBRANE EXPRESSION OF CD11B AND CD14 ON BLOOD NEUTROPHILS FOLLOWING IN-VIVO ADMINISTRATION OF MYELOID GROWTH-FACTORS (VOL 85, PG50, 1993), British Journal of Haematology, 86(1), 1994, pp. 240-240
IMPORTANCE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR FOR NEUTROPHIL MIGRATION
Authors: PEDERSEN TL PEDERSEN JO RYGAARD J RONNE E GRONDAHLHANSEN J DANO K HANSEN NE PLESNER T
Citation: Tl. Pedersen et al., IMPORTANCE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR FOR NEUTROPHIL MIGRATION, Blood, 84(10), 1994, pp. 10000032-10000032
THE BONE-MARROW INFILTRATION PATTERN IN CD5-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA HAS NO INDEPENDENT PROGNOSTIC-SIGNIFICANCE( B)
Authors: GEISLER CH HOUJENSEN K JENSEN OM TINGGAARDPEDERSEN N HANSEN MM HANSEN NE HOLM M CHRISTENSEN BE DRIVSHOLM A NIELSEN JB THORLING K ANDERSEN E LARSEN JK ANDERSEN PK
Citation: Ch. Geisler et al., THE BONE-MARROW INFILTRATION PATTERN IN CD5-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA HAS NO INDEPENDENT PROGNOSTIC-SIGNIFICANCE( B), Blood, 84(10), 1994, pp. 10000525-10000525
THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE IS TRANSLOCATED FROM 2 DISTINCT INTRACELLULAR COMPARTMENTS TO THE PLASMA-MEMBRANE ON STIMULATION OF HUMAN NEUTROPHILS
Authors: PLESNER T PLOUG M ELLIS V RONNE E HOYERHANSEN G WITTRUP M PEDERSEN TL TSCHERNING T DANO K HANSEN NE
Citation: T. Plesner et al., THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE IS TRANSLOCATED FROM 2 DISTINCT INTRACELLULAR COMPARTMENTS TO THE PLASMA-MEMBRANE ON STIMULATION OF HUMAN NEUTROPHILS, Blood, 83(3), 1994, pp. 808-815
EXPRESSION OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN NORMAL AND NEOPLASTIC BLOOD-CELLS AND HEMATOPOIETIC-TISSUE
Authors: PLESNER T RALFKIAER E WITTRUP M JOHNSEN H PYKE C PEDERSEN TL HANSEN NE DANO K
Citation: T. Plesner et al., EXPRESSION OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN NORMAL AND NEOPLASTIC BLOOD-CELLS AND HEMATOPOIETIC-TISSUE, American journal of clinical pathology, 102(6), 1994, pp. 835-841
HISTIOCYTIC SARCOMAS AND MONOBLASTIC LEUKEMIAS - A CLINICAL, HISTOLOGIC, AND IMMUNOPHENOTYPICAL STUDY
Authors: LAURITZEN AF DELSOL G HANSEN NE HORN T ERSBOLL J HOUJENSEN K RALFKIAER E
Citation: Af. Lauritzen et al., HISTIOCYTIC SARCOMAS AND MONOBLASTIC LEUKEMIAS - A CLINICAL, HISTOLOGIC, AND IMMUNOPHENOTYPICAL STUDY, American journal of clinical pathology, 102(1), 1994, pp. 45-54
Risultati: 1-25 | 26-34